Priority Date: 21.02.12 (US 201261601326P)
PHARMACEUTICAL COMPOSITION COMPRISING CD34+ CELLS
- Application ID: EP13710647
- Status: █ APPLICATION DEEMED TO BE WITHDRAWN
Attorney
operating since 1889
Headquarter in Nottingham
and
1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing
Specialization
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Potter Clarkson LLP is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 184 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.
Timeline
- 21.02.2012 - Priority Date (US 201261601326P)
- 29.08.2013 - Publication A2 (WO2013126590)
- 31.12.2014 - Publication A2 (EP2817014)